The Academy of Pharmaceutical Sciences
'Promoting the pharmaceutical sciences'


Faron Pharmaceutics reports inconsistent Traumakine biomarker results.....           Novartis targets Johnson & Johnson's Remicade, Amgen's Enbrel with biosimilar switching data.....           NICE dogs Roche's Perjeta again, this time in postsurgery breast cancer patients.....           FiercePharmaAsia?Sun?s key Halol plant, Eisai?s new Alzheimer?s center, Takeda-Shire opponents.....           Mylan scores FDA approval of generic Suboxone for opioid addiction, but a strong launch is no sure bet.....           Bristol-Myers? Opdivo ushers in a new era as the first I-O therapy approved in China.....           U.K. cost watchdogs turn away rare disease med Crysvita.....           ViiV?s dolutegravir/lamivudine regimen succeeds in two phase 3 HIV-1 trials.....           Sage, Shionogi to collaborate on MDD drug in three Asian countries.....           Faron?s FRDS treatment Traumakine fails to produce consistent interferon-beta bioactivity in phase III trial.....           Can Sanofi compete in lung cancer? With I-O med cemiplumab, it?s aiming for third.....           Talc attorney says J&J used law firm to shield contribution for journal article.....           Can Sanofi compete in lung cancer? With I-O med cemiplumab, it?s aiming for third.....           Massachusetts lawsuit names Purdue CEOs, Sackler family for alleged role in opioid epidemic.....           Merck's Keytruda nabs 2nd approval in 2 days, this time in non-Hodgkin lymphoma.....           Allergan brings in Abbott veteran for board position after investors demand change.....           FDA strikes down Mylan's generic Advair?again?citing 'minor' issues.....           Flex Pharma to stop two neuromuscular disease trials over safety concerns.....           FDA approves Roche's Avastin plus chemotherapy for ovarian cancer after surgery.....           Recipharm agrees to acquire Sanofi CMO business in UK.....           Merck's Keytruda snags I-O's first cervical cancer nod to back up HPV fighter Gardasil.....           Albireo gets FDA rare pediatric disease designation for rare liver disease treatment A4250.....           Merck's Keytruda snags I-O's first cervical cancer nod to back up HPV fighter Gardasil.....           Celeb-happy Allergan adds Helen Hunt, Trista Sutter and more to Alzheimer's push.....           Want to help patients? Get rid of drug rebates, HHS chief says.....           What?s a move to New Jersey worth? For Teva?s U.S. headquarters, $40M in tax breaks.....           Recipharm to buy Sanofi inhalation contract business and plant in U.K. for $60M.....           Merck's Keytruda secures FDA approval for advanced cervical cancer.....           Ascletis' Ganovo gets CFDA approval for treatment of viral hepatitis C.....           Grünenthal begins phase III trials in Complex Regional Pain Syndrome.....           GlaxoSmithKline to pass $10B in 2024 vaccine sales, with Merck, Sanofi and Pfizer rounding out the top 4: report.....           GlaxoSmithKline bids adieu to vaccines President Luc Debruyne as executive overhaul continues.....           Sanofi, Translate Bio ink mRNA vaccine R&D deal worth up to $805M.....           Advaxis doses first patient with ADXS-NEO cancer immunotherapy.....           AstraZeneca, Eli Lilly terminate clinical trials of Alzheimer's disease treatment lanabecestat.....           GlaxoSmithKline to pass $10B in 2024 vaccine sales, with Merck, Sanofi and Pfizer rounding out the top 4: report.....           After setting aside $200M, Endo settles 1,300 testosterone liability lawsuits.....           Sun Pharma finally free of FDA restrictions on its key plant in India.....           Merck rebuts petition urging SCOTUS to ignore Fosamax appeal.....           Sprout's old CEO is back, and she's got some new marketing ideas for female libido drug Addyi.....           GlaxoSmithKline bids adieu to vaccines president Luc Debruyne as executive overhaul continues.....           Sanofi Pasteur to buy license of Translate's mRNA technology in $805m deal.....           BridgeBio Pharma to acquire late stage therapy for ultra-rare disorder from Alexion.....           Allergan taps #WeAllGrow influencers for help steering Latinas to CoolSculpting.....           Doctors are coming around to Teva's Austedo as TD drugs get more play: analyst.....           WuXi Biologics to build U.S. plant as it rapidly moves beyond its China base.....           Old CEO, new chairman? Some Allergan investors want Pyott to come back: report.....           FDA approves AbbVie and Roche's Venclexta-rituximab combo for CLL.....           Alnylam's Lumasiran yields positive results in phase 1/2 Hyperoxaluria study.....           FDA accepts Cellenkos? IND to begin clinical trial of CK0801 for bone marrow failure syndromes.....           AstraZeneca gets EC nod for Tagrisso as first-line treatment for EGFR-mutated NSCLC.....           FDA beefs up generics-use push with radio PSAs.....           After a stormy year, Outcome Health says it's ready, steady and primed with new board members.....           GSK?s message to college-bound kids and their parents: Get meningitis B vaccine.....           Trust pharma? Not so much, annual survey shows, with biggest loss ever.....           What?s in a tweet? Sanofi's viral Roseanne retort draws kudos, followers and flak.....           RSS NEWSFEED....
Welcome to
The Academy of
Pharmaceutical Sciences
 
The Academy of Pharmaceutical Sciences (APS) is the UK-based professional membership body for Pharmaceutical Scientists.

We represent individuals and organisations from around the globe, throughout their development, in the delivery of excellence in the Pharmaceutical Science sector.
 
 
 
 
Latest news

Call for Nominations for the Eminent Fellowship and Fellowship of the Academy of Pharmaceutical Sciences (APS)

The APS is proud to announce a call for this year’s Nominations for two awards, the

  • Eminent Fellowship (Nominated by an APS member)

  • Fellowship of the Academy (Self-Nominated by an APS member)

These awards recognise and reward science from all sectors where Pharmaceutical Scientists work. The eminent fellowship will be presented at a social networking event held on Thursday 6th September followed by this year’s premier UK Pharmaceutical Sciences Conference, APS@FIP conference in 2018 which will take place in Glasgow on the 7th September 2018.

For more information, click here

Professional recognition for Pharmaceutical Science Degrees

The Academy of Pharmaceutical Sciences (APS) is delighted to announce that the pharmaceutical science course at the University of Greenwich has become the first APS accredited course having successfully completed the accreditation process set up by the Academy towards the end of 2017.

This is the first time that a pharmaceutical science course has been accredited in the United Kingdom and it is also, we believe, a world first.

Achieving accreditation gives assurance to students and employers that the course meets the high standards required by the Academy and that these standards will be maintained throughout the 5-year period of accreditation.

APS believes that the accreditation process will raise the profile of pharmaceutical sciences in both academia and industry. The discipline is key in the discovery, development and manufacture of new medicines and as such is central to government initiatives to encourage the pharmaceutical industry to maintain and strengthen its strong base here in the UK.

The Academy will continue to work with other stakeholders to build the science base for the ultimate benefit of patients.

 
 
APS events overview

The APS has developed an exciting and informative programme for our events in 2018.

Don’t forget to make a note of APS@FIP, linking with the 78th FIP World Congress of Pharmacy and Pharmaceutical Science conference.

Please take a look at our programme, with event summaries, below:

Nanomedicines for the Delivery of Biologics
18 July 2018 - University of Reading
Under the auspices of APS, with special insight from the Nanomedicine focus group, we are proud to announce this new one-day special symposium. This one-day symposium builds on the Recent Emerging Technologies in Therapeutic Oligonucleotides conference in Cambridge, March 2018. We are bringing together world-class speakers with expertise in nanomedicines for the delivery of biologics spanning from bench to bedside. We have assembled an outstanding speaker line-up which includes, but is not limited to, Prof Awyn Jones (University of Cardiff), Prof Yvonne Perrie (University of Strathclyde) and Prof Len Seymour (University of Oxford).
To learn more and to register, click here

APS@FIP
7 September 2018 - Hilton Hotel, Glasgow
Linking with the 78th FIP World Congress of Pharmacy and Pharmaceutical Science conference, which will take place in the city from the 2 - 6 September 2018. The theme of this conference in 2018 is 'The Science of Differentiated Medicines'.
To learn more and to register, click here

OTHER EVENTS IN DEVELOPMENT
OrBiTo (Innovative Tools for Oral Biopharmaceutics) Conference
Developability for Biologicals
Inhaled Workshop
Basic Biopharmaceutics workshop 


Follow us
 
Upcoming Events
APS Nanomedicines for the Delivery of Biologics
18 July 2018
APS@FIP
7 September 2018
Job Vacancies
View all Vacancies
Advertise your job vacancies
The APS is grateful for the support of:
Join Us

Join the academy and get discounts on events, post-nominals, latest news and more.

 

The Academy of Pharmaceutical Sciences
Unit Q, Troon Way Business Centre
Humberstone Lane, Leicester, LE4 9HA
Tel: 0116 274 7351, Fax: 0116 274 7365, Email: info@apsgb.org

Terms of use:
The material included on this site is provided for information purposes only, and we make no representations or warranties as to its accuracy. Before relying on this material, you should take care to verify its accuracy, taking professional advice as appropriate.

Privacy Policy:
For details on the data we collect and how we store and process your data please refer to our Privacy Policy.